These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25990417)

  • 1. Cost-effectiveness of liver transplantation in methylmalonic and propionic acidemias.
    Li M; Dick A; Montenovo M; Horslen S; Hansen R
    Liver Transpl; 2015 Sep; 21(9):1208-18. PubMed ID: 25990417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review.
    Pillai NR; Stroup BM; Poliner A; Rossetti L; Rawls B; Shayota BJ; Soler-Alfonso C; Tunuguntala HP; Goss J; Craigen W; Scaglia F; Sutton VR; Himes RW; Burrage LC
    Mol Genet Metab; 2019 Dec; 128(4):431-443. PubMed ID: 31757659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom.
    Bretos-Azcona PE; Wallace M; Jootun M; Jin G; Agirrezabal I; Szende A
    Clin Drug Investig; 2024 Jun; 44(6):399-412. PubMed ID: 38796677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.
    Thiboonboon K; Leelahavarong P; Wattanasirichaigoon D; Vatanavicharn N; Wasant P; Shotelersuk V; Pangkanon S; Kuptanon C; Chaisomchit S; Teerawattananon Y
    PLoS One; 2015; 10(8):e0134782. PubMed ID: 26258410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylmalonic acidemia/propionic acidemia - the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groups.
    Chu TH; Chien YH; Lin HY; Liao HC; Ho HJ; Lai CJ; Chiang CC; Lin NC; Yang CF; Hwu WL; Lee NC; Lin SP; Liu CS; Hu RH; Ho MC; Niu DM
    Orphanet J Rare Dis; 2019 Apr; 14(1):73. PubMed ID: 30940196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Transplantation for Propionic Acidemia and Methylmalonic Acidemia: Perioperative Management and Clinical Outcomes.
    Critelli K; McKiernan P; Vockley J; Mazariegos G; Squires RH; Soltys K; Squires JE
    Liver Transpl; 2018 Sep; 24(9):1260-1270. PubMed ID: 30080956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver and/or kidney transplantation in amino and organic acid-related inborn errors of metabolism: An overview on European data.
    Molema F; Martinelli D; Hörster F; Kölker S; Tangeraas T; de Koning B; Dionisi-Vici C; Williams M;
    J Inherit Metab Dis; 2021 May; 44(3):593-605. PubMed ID: 32996606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.
    Baumgartner MR; Hörster F; Dionisi-Vici C; Haliloglu G; Karall D; Chapman KA; Huemer M; Hochuli M; Assoun M; Ballhausen D; Burlina A; Fowler B; Grünert SC; Grünewald S; Honzik T; Merinero B; Pérez-Cerdá C; Scholl-Bürgi S; Skovby F; Wijburg F; MacDonald A; Martinelli D; Sass JO; Valayannopoulos V; Chakrapani A
    Orphanet J Rare Dis; 2014 Sep; 9():130. PubMed ID: 25205257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective evaluation of the Dutch pre-newborn screening cohort for propionic acidemia and isolated methylmalonic acidemia: What to aim, expect, and evaluate from newborn screening?
    Haijes HA; Molema F; Langeveld M; Janssen MC; Bosch AM; van Spronsen F; Mulder MF; Verhoeven-Duif NM; Jans JJM; van der Ploeg AT; Wagenmakers MA; Rubio-Gozalbo ME; Brouwers MCGJ; de Vries MC; Langendonk JG; Williams M; van Hasselt PM
    J Inherit Metab Dis; 2020 May; 43(3):424-437. PubMed ID: 31828787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a signs and symptoms outcome measure for caregivers of patients with methylmalonic acidemia and propionic acidemia (MMAPAQ).
    Sikirica V; Schwartz EJ; Vockley J; Stagni K; Bellenger MA; Banerjee G; Durgam N; Moshkovich O
    Mol Genet Metab; 2024; 143(1-2):108577. PubMed ID: 39303317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and management of organic acidemias in Japan.
    Fujisawa D; Nakamura K; Mitsubuchi H; Ohura T; Shigematsu Y; Yorifuji T; Kasahara M; Horikawa R; Endo F
    J Hum Genet; 2013 Dec; 58(12):769-74. PubMed ID: 24067294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of long-term effectiveness of the use of carglumic acid in patients with propionic acidemia (PA) or methylmalonic acidemia (MMA): study protocol for a randomized controlled trial.
    Nashabat M; Obaid A; Al Mutairi F; Saleh M; Elamin M; Ahmed H; Ababneh F; Eyaid W; Alswaid A; Alohali L; Faqeih E; Aljeraisy M; Hussein MA; Alasmari A; Alfadhel M
    BMC Pediatr; 2019 Jun; 19(1):195. PubMed ID: 31196016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Illness Protocol for Organic Acidemias: Methylmalonic Acidemia and Propionic Acidemia.
    Aldubayan SH; Rodan LH; Berry GT; Levy HL
    Pediatr Emerg Care; 2017 Feb; 33(2):142-146. PubMed ID: 28141776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of a quality-adjusted life year in liver transplantation: the influence of the indication and the model for end-stage liver disease score.
    Åberg F; Mäklin S; Räsänen P; Roine RP; Sintonen H; Koivusalo AM; Höckerstedt K; Isoniemi H
    Liver Transpl; 2011 Nov; 17(11):1333-43. PubMed ID: 21770017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for organic acidemias: Lessons learned from methylmalonic and propionic acidemia.
    Chandler RJ; Venditti CP
    J Inherit Metab Dis; 2024 Jan; 47(1):63-79. PubMed ID: 37530705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of endovascular repair, open repair, and conservative management of splenic artery aneurysms.
    Hogendoorn W; Lavida A; Hunink MG; Moll FL; Geroulakos G; Muhs BE; Sumpio BE
    J Vasc Surg; 2015 Jun; 61(6):1432-40. PubMed ID: 25827968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of propionic and methylmalonic acidemias. Part 2: Treatment strategies.
    Haijes HA; van Hasselt PM; Jans JJM; Verhoeven-Duif NM
    J Inherit Metab Dis; 2019 Sep; 42(5):745-761. PubMed ID: 31119742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylmalonic and propionic acidemias: clinical management update.
    Fraser JL; Venditti CP
    Curr Opin Pediatr; 2016 Dec; 28(6):682-693. PubMed ID: 27653704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First revision.
    Forny P; Hörster F; Ballhausen D; Chakrapani A; Chapman KA; Dionisi-Vici C; Dixon M; Grünert SC; Grunewald S; Haliloglu G; Hochuli M; Honzik T; Karall D; Martinelli D; Molema F; Sass JO; Scholl-Bürgi S; Tal G; Williams M; Huemer M; Baumgartner MR
    J Inherit Metab Dis; 2021 May; 44(3):566-592. PubMed ID: 33595124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for drug development in propionic and methylmalonic acidemias.
    Longo N; Sass JO; Jurecka A; Vockley J
    J Inherit Metab Dis; 2022 Mar; 45(2):132-143. PubMed ID: 35038174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.